CXCR4 and B-cell chronic lymphocytic leukemia: CXCR4 has been identified as a key regulator in CLL-cell retention in bone marrow and lymphoid tissues and it has recently been shown that BTK inhibition impairs CXCR4 expression in B-CLL [29].